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Fibroblast growth factor (FGF) receptors (FGFRs) signal to modulate diverse cellular functions, including epithelial cell
morphogenesis. In epithelial cells, E-cadherin plays a key role in cell-cell adhesion, and its function can be regulated
through endocytic trafficking. In this study, we investigated the location, trafficking, and function of FGFR1 and
E-cadherin and report a novel mechanism, based on endocytic trafficking, for the coregulation of E-cadherin and signaling
from FGFR1. FGF induces the internalization of surface FGFR1 and surface E-cadherin, followed by nuclear translocation
of FGFR1. The internalization of both proteins is regulated by common endocytic machinery, resulting in cointernaliza-
tion of FGFR1 and E-cadherin into early endosomes. By blocking endocytosis, we show that this is a requisite, initial step
for the nuclear translocation of FGFR1. Overexpression of E-cadherin blocks both the coendocytosis of E-cadherin and
FGFR1, the nuclear translocation of FGFR1 and FGF-induced signaling to the mitogen-activated protein kinase pathway.
Furthermore, stabilization of surface adhesive E-cadherin, by overexpressing p120ctn, also blocks internalization and
nuclear translocation of FGFR1. These data reveal that conjoint endocytosis and trafficking is a novel mechanism for the
coregulation of E-cadherin and FGFR1 during cell signaling and morphogenesis.
INTRODUCTION
The fibroblast growth factor (FGF) family consists of 22
pleiotropic mammalian ligands intimately involved in early
embryo patterning and development (Martin, 1998; Ornitz
and Itoh, 2001). In the adult, FGFs have been implicated as
key players in tumorigenesis (Dickson et al., 2000). FGFs and
their cognate receptors (FGFRs) also are involved in epithe-
lial to mesenchymal transitions (EMTs) (Thiery, 2002), and
accordingly, have emerged as regulators of cell fate. Recep-
tor activation by FGFs involves high-affinity binding to the
type I transmembrane FGFRs, a family of four genes, and
lower affinity binding to heparin sulfate proteoglycans
(Johnson and Williams, 1993). At the cell surface, these three
elements interact as heterotrimers to form the ternary FGF
signaling complex (Ornitz, 2000). Complexity of signaling
interactions is greatly increased by alternate splicing of some
FGF ligands and of all FGFRs (Johnson and Williams, 1993;
Ornitz et al., 1996; Prudovsky et al., 1996; Ornitz and Itoh,
2001).
Ligand-bound FGFRs can signal through a number of
different pathways, including through mitogen-activated
protein kinase (MAPK) and -catenin, depending on the
cellular context (Klint and Claesson-Welsh, 1999). On li-
gand-mediated activation of surface receptor, the FGF sig-
naling complex is internalized (Sorokin et al., 1994; Pru-
dovsky et al., 1996; Belleudi et al., 2002). The intracellular
trafficking of FGFs and FGFRs is poorly defined, with a
variety of fates described for different ligand and receptor
combinations, as well as splice variants. In some contexts,
both FGF and FGFR are translocated into a subcompartment
of the nucleus (Wiedlocha et al., 1994; Maher, 1996; Reilly
and Maher, 2001). Although nuclear translocation of FGFRs
is dependent on cAMP and importin- (Reilly and Maher,
2001), the pathway and mechanisms involved in this trans-
location are poorly understood.
The incorporation of adhesion molecules and receptor
tyrosine kinases (RTKs) into functional complexes is an
emerging paradigm (e.g., VE-cadherin with VEGFR2; EGFR,
IGF1-R, or c-Met with E-cadherin) (reviewed in Cavallaro
and Christofori, 2004). The functional consequences of such
complexes are varied, having the potential to regulate both
signaling and adhesion, but the relevant mechanisms are
still not fully understood (Cavallaro and Christofori, 2004).
A number of cell adhesion proteins, such as N-CAM and
N-cadherin, can form part of a signaling complex with FG-
FRs in a range of cell types (Cavallaro et al., 2001; Suyama et
al., 2002). Stimulation of epithelial cells with FGF results in
scattering, and in some cases, induction of EMT events
(Savagner et al., 1997; Thiery, 2002), which depend directly
on transcriptional down-regulation of E-cadherin levels and
also involve Wnt/-catenin signaling (Ciruna and Rossant,
2001). A direct interaction between FGFRs and N-cadherin
has been demonstrated in both neuronal and epithelial cells
(Doherty and Walsh, 1996; Suyama et al., 2002), but to date
no evidence has arisen for any potential cellular association
of FGFR with E-cadherin, which would potentially have
different physiological consequences.
E-cadherin, the prototypical epithelial cadherin, is local-
ized to the lateral surface of polarized epithelial cells, where
it is concentrated in adherens junctions and mediates adhe-
sion to adjacent cells in a Ca2-dependent homotypic man-
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ner (Yap et al., 1997). The conserved intracellular domain of
E-cadherin supports interactions with the Src substrate
p120ctn, and either -catenin or -catenin, and -catenin for
coupling to F-actin (Yap, 1998). -Catenin is involved in
transduction of the Wnt signaling pathway, also translocat-
ing to the nucleus where it has key roles in early embryo
patterning, cell polarity, and cellular transformation during
many forms of metastasis (Gottardi and Gumbiner, 2001;
Nelson and Nusse, 2004). p120ctn has multiple signaling
roles, as well as influencing cadherin adhesive strength and
acting as a molecular “stabilizer” of E-cadherin at adherens
junctions (Yap et al., 1998; Daniel and Reynolds, 1999; Anas-
tasiadis et al., 2000; Davis et al., 2003; Xiao et al., 2003).
The endocytosis of cadherins, with subsequent recycling
back to the plasma membrane, has emerged as a key mech-
anism to dynamically regulate cell-cell adhesion, signaling,
and morphogenesis (reviewed in Bryant and Stow 2004).
Cadherins are endocytosed via a number of different routes,
including both clathrin-dependent and clathrin-indepen-
dent pathways. Stabilization of E-cadherin at the plasma
membrane by p120ctn inversely regulates levels of E-cad-
herin endocytosis and cadherin turnover (Davis et al., 2003;
Xiao et al., 2003), as does an interplay between active Rac,
Cdc42, and IQGAP (Izumi et al., 2004). Src or RTK-induced
modulation of tyrosine phosphorylation regulates the integ-
rity of the cadherin/catenin complex (Behrens and Birch-
meier, 1994; Daniel and Reynolds, 1997), and subsequent
ubiquitylation of tyrosine-phosphorylated E-cadherin by the
E3 ubiquitin ligase Hakai can induce endocytosis of E-cad-
herin (Fujita et al., 2002). Because signaling from RTKs can
induce the internalization of E-cadherin, there is the possi-
bility for coendocytosis of activated RTKs with cadherins as
a novel mechanism for regulating cadherin adhesive dy-
namics. In developmental systems, E-cadherin expression
and adhesive function seems to lay downstream of FGFR
signaling (Ciruna and Rossant, 2001; Chihara et al., 2003).
In light of the emerging evidence for interaction of RTKs
and adhesion molecules, generating a range of different
physiological consequences, we set out to examine possible
cotrafficking of FGFR1 and E-cadherin. Moreover, we show
that cotrafficking of an RTK with E-cadherin is a possible
mechanism for the joint regulation of both signaling and
adhesion.
MATERIALS AND METHODS
Cell Culture and Treatments
Human breast adenocarcinoma (MCF-7) cell monolayers were grown in
minimal essential medium (Earle’s Salts) supplemented with 10% fetal calf
serum, 20 mM HEPES, 2 g/l sodium bicarbonate, 4 mM l-glutamine, 1%
nonessential amino acids, and 5 g/ml insulin at 37°C in 5% CO2, 95% air, as
described previously (Nurcombe et al., 2000). Cells were plated on glass
coverslips at varying densities for experiments. For some experiments, cells
were incubated with either FGF-1 and 5 g/ml heparin or FGF-2 (both at 10
ng/ml) (Sigma-Aldrich, Castle Hill, Australia) for various times in either
complete medium or after incubation in serum-free medium for 18 h at 37°C.
For some endocytosis assays, cells were treated with 10 M cycloheximide at
37°C to block protein synthesis.
Antibodies and Reagents
E-cadherin was detected using mouse monoclonal (HECD-1) and rabbit poly-
clonal antibodies to human E-cadherin (Dr. Alpha Yap, University of Queens-
land, Brisbane, Australia) or a mouse monoclonal anti-E-cadherin antibody
(BD Transduction Laboratories, Lexingon, CA) for Western blotting. Rabbit
polyclonal -catenin (Sigma-Aldrich), mouse monoclonal tubulin and green
fluorescent protein (GFP) (Molecular Probes, Eugene, OR) antibodies also
were used. Mouse monoclonal myc antibody is as described previously (Evan
et al., 1985). Mouse monoclonal -catenin, p120ctn, and EEA1 antibodies (BD
Transduction Laboratories) and rabbit polyclonal FGFR1, mitogen-activated
protein kinase kinase (MEK)-1, MEK-2, extracellular signal-regulated kinase
(ERK)-1 and ERK-2 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA)
were used. Rabbit polyclonal phospho-MEK1/2 and mouse monoclonal phos-
pho-ERK1/2 antibodies were from Cell Signaling Technology (GeneSearch,
Arundel, Australia). Secondary antibodies were Cy3-conjugated sheep anti-
mouse and goat anti-rabbit IgGs (Jackson ImmunoResearch Laboratories,
West Grove, PA), Alexa 488-conjugated goat anti-rabbit and goat anti-mouse
IgGs (Molecular Probes), and horseradish peroxidase-conjugated sheep anti-
mouse IgG and goat anti-rabbit IgG (Amrad, Victoria, Australia). Alexa
488-conjugated phalloidin, used to label F-actin, and 4,6-diamidino-2-phe-
nylindole (DAPI), used to label nuclei, were both from Molecular Probes.
Cycloheximide was purchased from Sigma-Aldrich.
cDNA Constructs and Transfection
A plasmid encoding full-length human E-cadherin-GFP (C-terminally tagged)
is as described previously (Miranda et al., 2003). A GTPase-deficient mutant of
Rab5 with either a GFP tag (Rab5Q79L-GFP) or a myc tag (Rab5Q79L-myc), and
GFP-tagged dominant negative mutant of Rab5 (Rab5S34N-GFP), as well as
GFP-tagged dominant-negative Eps15 (pEGFP-Eps15/E95/295) were kindly
provided by Dr. R. Parton (The University of Queensland). A plasmid encod-
ing human FGFR1 was a generous gift from Dr. I. Prudovsky (Maine Medical
Centre Research Institute, Scarborough, ME) and was cloned into the
pEGFP-N1 expression vector to give C-terminally GFP-tagged FGFR1
(FGFR1-GFP). Hemagglutinin (HA)-tagged Dynamin2K44A was kindly pro-
vided by Dr. He Li (Monash University, Melbourne, Australia). HA-tagged
ARF6T27N and p120-GFP were kindly provided by Dr. Julie Donaldson
(National Institutes of Health, Bethesda, MD) and Dr .Alpha Yap, respec-
tively. The empty vector pEGFP-N1 was from BD Biosciences Clontech (Palo
Alto, CA).
MCF-7 cells were plated at subconfluent densities 24 h before transfection.
Plasmids were transfected using the LipofectAMINE Plus system (Invitrogen,
Carlsbad, CA) as per the manufacturer’s instructions. Cells were typically left
for 18–36 h posttransfection before use. For stable expression, transfected cells
were passaged and maintained in G-418–containing medium (Geneticin;
Invitrogen) for 10–14 d. Surviving cells were ring-cloned and grown to
confluence before being subjected to immunofluorescence and immunoblot-
ting to select lines with appropriate levels of recombinant protein expression.
Immunofluorescence
Cells grown on filters or glass coverslips were fixed in 4% paraformaldehyde
in phosphate-buffered saline for 60 min, permeabilized using 0.1% Triton
X-100 for 5 min, and then stained as described previously (Miranda et al.,
2001). Cells were viewed using an Olympus Provis AX-70 microscope with
40–100 objective lenses, or a Bio-Rad Radiance 2000 confocal microscope.
Images were analyzed and adjusted using Adobe Photoshop 7 and ImageJ
(National Institutes of Health) as described previously (Miranda et al., 2003).
Immunoblotting
Cells were solubilized in ice-cold extraction buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 0.5 mM MgCl2, 0.2 mM EGTA, and 1% Triton Tx-100) on ice
for 5 min and then extracted at 4°C for 45 min. Postnuclear supernatants were
obtained by centrifugation at 14,000  g for 10 min. Samples were separated
by SDS-PAGE, transferred to polyvinylidene difluoride membranes, and
analyzed by immunoblotting by using chemiluminescence (SuperSignal
chemiluminescence kits; Pierce Chemical, Rockford, IL) (Miranda et al., 2001).
Protein concentrations were determined using a BCA Protein Assay Reagent
kit (Pierce Chemical); protein transfer and loading were assessed by staining
with 0.1% Coomassie Brilliant Blue, and immunolabeling was assessed by
densitometry using a Bio-Rad GS-800 densitometer.
RESULTS
FGF Induces Nuclear Translocation of FGFR1 and
Internalization of E-Cadherin
MCF-7 cells maintain a polarized morphology, express E-
cadherin, and proliferate and migrate in response to FGF
(Nurcombe et al., 2000; Paterson et al., 2003). MCF-7 cells
were immunolabeled to localize FGFR1 and E-cadherin over
a time course of FGF stimulation. In unstimulated cells, cell
surface staining of endogenous FGFR1 was barely detectable
using available antibodies; however, some staining was ap-
parent on membrane ruffles (Figure 1A, arrowheads), and
there was also diffuse staining through the cytoplasm, as
noted previously (Johnston et al., 1995). Stimulation with
FGF-1 resulted in the accumulation of FGFR1 staining in cell
nuclei (arrows); beginning at 1 h, with more intense staining
noted at 4 h (Figure 1A). Nuclear staining persisted during
prolonged incubation in FGF-1 (up to 24 h) (Figures 1B and
5A, bottom). The intranuclear localization of FGFR1 was
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confirmed by colocalization with DAPI staining (Figure 1B).
Stimulation of MCF-7 cells with FGF-2 also resulted in a
similar nuclear translocation of FGFR1 (Figure 4B). Thus,
FGF induces trafficking of FGFR1 to the nucleus in MCF-7
cells.
We next examined the localization of endogenous E-cad-
herin in ligand-stimulated cells. In unstimulated MCF-7
cells, E-cadherin was found predominantly on lateral cell
membranes (Figure 2A). Soon after incubation with FGF-1,
punctate intracellular staining of E-cadherin occurred (Fig-
ure 2A). FGF-1 caused a progressive loss of E-cadherin
staining at the cell surface, concomitant with morphological
changes, signified by a loss of the cobblestone appearance of
the cell monolayer and the spreading and movement of cells.
E-cadherin staining progressively occurred in the punctate
intracellular pattern (Figure 2A), consistent with its endocy-
tosis (Le et al., 1999; Paterson et al., 2003). Similar results
were obtained by incubation of cells with FGF-2 (our un-
published data). Thus, FGF induces translocation of E-cad-
herin staining from the cell surface to an intracellular pool.
To confirm the endocytic nature of this FGF-induced inter-
nal pool of E-cadherin, MCF-7 cells were preincubated with
cycloheximide. Blocking protein synthesis did not eliminate
the vesicular labeling of E-cadherin induced by FGF stimu-
lation (Figure 2B), indicating that it is not newly synthesized
E-cadherin. Furthermore, marked accumulation of E-cad-
herin in intracellular vesicles occurred after repeating these
treatments at 18°C instead of 37°C, a technique previously
shown to accumulate E-cadherin in early or sorting endoso-
mal compartments (Le et al., 1999). Finally, intracellular
E-cadherin was colocalized with an early endosomal
marker, EEA1, in some vesicles in FGF-stimulated cells (Fig-
ure 2C). Thus, in MCF-7 cells, FGF disrupts epithelial cell-
cell contacts and induces endocytosis of surface E-cadherin.
The internalization of both FGFR1 and E-cadherin in re-
sponse to FGF led us to examine possible coendocytosis and
trafficking of both proteins. Because endogenous FGFRs are
present at relatively low levels in MCF-7 cells (Johnston et
al., 1995; Nurcombe et al., 2000) and are difficult to immu-
nolabel at cell membranes (Figure 1; Maher, 1996), MCF-7
cells were transiently transfected with a GFP-tagged FGFR1
(FGFR1-GFP). FGFR1-GFP was expressed both at the cell
surface of serum-grown MCF-7 cells (Figure 3A, top), and in
intracellular puncta. Stimulation with FGF-1 resulted in the
loss of membrane labeling of FGFR1-GFP (Figure 3A, bot-
tom). Expression of FGFR1-GFP in serum-grown cells re-
sulted in a decrease of total and plasma membrane-associ-
ated E-cadherin labeling, concomitant with the appearance
of exaggerated internal punctate labeling (Figure 3A), con-
sistent with endocytosis of E-cadherin in response to FGFR1
activation (Figure 2). Internalized FGFR1-GFP was found to
localize with endogenous E-cadherin in a proportion of en-
dosomes, in both serum-grown cells (Figure 3A, top) and
cells treated with FGF-1 (Figure 3A, bottom). Confocal imag-
ining of FGFR1-GFP-transfected cells treated with FGF-1
again confirmed the coincident labeling of E-cadherin in a
subset of endosomes (Figure 3A, bottom insets). The inter-
nalization of E-cadherin into Rab5- and EEA-1–positive
early endosomes has been well documented in both Madin-
Darby canine kidney and MCF-7 cells (Le et al., 1999; Pater-
son et al., 2003) and also was seen in response to FGF
stimulation in MCF-7 cells transfected with a constitutively
active mutant GFP-Rab5Q79L (Figure 2 and 3B, top, arrows).
When MCF-7 cells were cotransfected with a myc-tagged
Rab5Q79L and FGFR1-GFP and stimulated with FGF-1, the
FGFR1-GFP also was found in enlarged early endosomes
induced by Rab5Q79L (Figure 3B, top, arrows), characteristic
of longer duration expression of this mutant (Stenmark et al.,
1994). Distinct localization of internal FGFR1-GFP to these
enlarged Rab5-positive endosomes is demonstrated in Fig-
ure 3B (insets). Thus, surface E-cadherin and FGFR1 are
cointernalized into early endosomal compartments in re-
sponse to FGF stimulation.
Endocytosis Is an Essential, Early Step in Nuclear
Translocation of FGFR1
Our data suggest that ligand-activated FGFR1 is internalized
from the cell surface in what could be the initial step in
nuclear accumulation of FGFR1. To test this, MCF-7 cells
were transfected with functional mutants of endocytic ma-
chinery proteins to block endocytosis by different routes.
Overall, nuclear staining of FGFR1 was recorded in40% of
serum-grown MCF-7 cells, and this incidence increased to
90% after stimulation with FGF-1 or FGF-2 (Figure 4B),
whereas serum-starved cells had virtually no nuclear stain-
ing (Figure 5A, top). Expression of Rab5Q79L-GFP resulted in
a more than threefold reduction in FGF-1– or FGF-2–stimu-
lated cells with nuclear FGFR1. After longer incubations in
FGF-1, cells expressing Rab5Q79L-GFP had no nuclear stain-
ing of FGFR1 in contrast to surrounding cells with promi-
nent nuclear FGFR1 (Figure 4A, top). Rab5Q79L-GFP expres-
sion experiments also served to highlight that both FGF-1
and FGF-2 produce equivalent internalization of FGFR1
(Figure 4B). Consistent with this, a dominant-negative mu-
tant of Rab5 (Rab5S34N-GFP) also blocked nuclear translo-
cation of FGFR1 in response to FGF-1 stimulation, at similar
levels (Figure 4C). Expression of a dominant-negative mu-
tant of dynamin 2 (HA-Dyn2K44A) (which functions at both
the plasma membrane and Golgi network) (Praefcke and
McMahon, 2004) additionally was able to block nuclear
translocation of FGFR1 (Figure 4A, middle), resulting in
only 15% of transfected cells with nuclear staining (Figure
4C), whereas surrounding untransfected cells had consistent
Figure 1. FGF induces nuclear translocation of FGFR1. (A) MCF-7
cells incubated with FGF-1 for 0–4 h at 37°C were fixed and stained
by immunofluorescence by using a polyclonal antibody against
endogenous FGFR1. Arrowheads indicate membrane labeling that
was only evident on membrane ruffles, whereas arrows denote
nuclear FGFR1 labeling. At higher magnification the FGFR1 can be
seen inside cell nuclei (inset). (B) MCF-7 cells were incubated with
FGF-1 for 24 h at 37°C were fixed and triple labeled using an
antibody against endogenous FGFR1, phalloidin to label F-actin in
the cell periphery, and DAPI to label cell nuclei. FGFR1 staining
overlaps with DAPI-stained nuclei. Bar, 50 m.
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nuclear labeling of FGFR1. Dominant-negative ARF6 (HA-
ARF6T27N), which we have previously shown to block E-
cadherin endocytosis in MCF-7 cells (Paterson et al., 2003),
also reduced nuclear FGFR1 labeling to 10% of transfected
cells (Figure 4C). Expression of either a dominant-negative
mutant of the clathrin endocytosis machinery component,
Eps15 (DN-Eps15-GFP), or of EGFP alone, did not signifi-
cantly reduce the incidence of nuclear translocation of
FGFR1 in response to FGF (Figure 4, B and C). Interestingly,
this mutant is also unable to block internalization of E-
cadherin (Paterson et al., 2003). These data confirm that
similar endocytic machinery is responsible for the uptake of
FGFR1 and E-cadherin (Paterson et al., 2003) in MCF-7 cells.
Importantly, these experiments also show that traffic into an
early endosome is an essential first step in the nuclear trans-
location of FGFR1.
E-Cadherin Modulates FGFR1 Endocytosis and Nuclear
Translocation
Based on the endocytosis of both E-cadherin and FGFR1 in
response to FGF stimulation, we next examined a possible
direct role for E-cadherin in regulating the internalization
and nuclear translocation of FGFR1. MCF-7 cells were
grown to 80% confluence, serum-starved for 18 h, and
stimulated with FGF-1 for 24 h to induce both nuclear trans-
location of FGFR1 and extensive endocytosis of surface E-
cadherin. Overall, there was a significant change in the
morphology of cells, including disruption of the epithelial
monolayer (as noted in Figure 1), cell spreading, and cell
motility (Figure 5A). E-cadherin staining revealed the ap-
pearance of irregular, jagged cell-cell contacts. Interestingly,
nuclear labeling of FGFR1 was inversely correlated to reten-
tion of adherens junctions and epithelial polarity, with nu-
clear FGFR1 only observed in cells with disrupted E-cad-
herin-based cell-cell contacts (Figure 5A, outside outline).
MCF-7 cells were then transiently transfected to overex-
press E-cadherin-GFP, stimulated with FGF-1, and then
fixed and stained for endogenous FGFR1. In nontransfected
cells, FGF-1 stimulation induced nuclear translocation of
FGFR1 (Figure 5B), whereas in contrast, cells overexpressing
E-cadherin-GFP had no nuclear FGFR1 labeling (Figure 5B).
Quantification of this effect revealed a marked suppression
by E-cadherin (8-fold) on the incidence of nuclear translo-
cation of FGFR1 induced by either serum, FGF-1, or FGF-2
(Figure 5D). MCF-7 cell lines stably overexpressing E-cad-
herin-GFP (to 2-fold) (Figure 5E) also were treated with
FGF-1 for 2 h and then fixed and stained for localization of
endogenous FGFR1. In these cells where overexpressed E-
Figure 2. FGF induces internalization of E-cad-
herin into early endosomes. (A) MCF-7 cells were
incubated with FGF-1 at 37°C for 0–4 h, fixed, and
stained by immunofluorescence by using an anti-
human E-cadherin antibody. Staining is seen on lat-
eral cell membranes and increasingly in intracellular
vesicles. (B) MCF-7 cells were incubated with 10 mM
cycloheximide (CHX) for 2.5 h to halt new protein
synthesis, fixed, and stained for endogenous E-cad-
herin. Internal vesicular E-cadherin labeling was de-
pleted after CHX treatment at 37°C (left) but reap-
peared after addition of FGF-1 during the last 2 h of
CHX treatment (middle). Insets demonstrate higher
magnification of dotted regions. Incubation of cells
at 18°C under the same conditions resulted in a
marked accumulation of endosomal E-cadherin
staining (right). (C) Preconfluent MCF-7 cells stimu-
lated with FGF-1 for 2 h at 37°C were fixed and
double stained by using antibodies against E-cad-
herin (green) and EEA1 (red). Arrows denote exam-
ples of E-cadherin and EEA1 colocalized in early
endosomes. Inset depicts higher magnification of
boxed region to emphasize colocalization. Bar, 50 m.
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cadherin-GFP was largely at the cell surface, there was no
nuclear translocation of FGFR1 (Figure 5C), further confirm-
ing the results in transiently transfected cells. A major find-
ing of these experiments is thus that E-cadherin levels and
intact adherens junctions directly and inversely regulate
FGFR1 nuclear translocation. To examine the possibility that
E-cadherin levels might influence the expression of FGFR1,
immunoblotting was performed on extracts of wild-type
and E-cadherin-GFP stably overexpressing cells. Total
FGFR1 levels were unchanged by overexpression of E-cad-
herin and were also not influenced by treatment with FGF-1
(2 h) (Figure 5E). Thus, the effects of E-cadherin on FGF-
induced nuclear translocation of FGFR1 are purely attribut-
able to suppressing its trafficking to this compartment.
E-Cadherin Attenuates FGF Signaling to the MAPK
Pathway
Translocation of FGF ligand to the nucleus is involved in
signaling to the MAPK pathway (Wiedlocha et al., 1994).
Thus, inhibition of FGFR1 nuclear translocation by E-cad-
herin overexpression has the potential to influence such
signaling. To test this, wild-type MCF-7 cells (wt-MCF-7)
and clonal populations of MCF-7 cells stably overexpressing
E-cadherin-GFP (hE-GFP-MCF-7) were used to compare
MEK and ERK activation. Cells were initially grown to
confluence, serum-starved for 18 h, and then stimulated
with FGF-1 for various times. In wild-type MCF-7 cells,
stimulation with FGF-1 resulted in activation of MEK1/2 in
the first 10 min, followed by reduced but still strong levels at
2 and 18 h after treatment, even increasing slightly at the
latter time point (Figure 6). Robust activation of ERK1/2
occurred by 10 min of stimulation; thereafter activation was
sustained at a reduced level by 18 h (Figure 6). hE-GFP-
MCF-7 cells displayed markedly reduced MEK1/2 activa-
tion across the time course of FGF stimulation (Figure 6).
Interestingly, densitometry of immunoblots revealed the ex-
tent of this inhibition (20-fold reduction at 10 min) but also
revealed an activation pattern for MEK1/2 in hE-GFP-
MCF-7 cells, similar to wild-type MCF-7 cells, albeit at a
much less robust level (Figure 6). In hE-GFP-MCF-7 cells,
there was a severe reduction in the levels of p-ERK and its
persistence over the time course, with no detectable signal
by 18 h (Figure 6). Equal amounts of protein were loaded for
all conditions, as detected by immunoblotting for total
MEK1/2 and ERK1/2. These results show that E-cadherin
overexpression attenuated signaling of FGFR1 to both MEK
and particularly ERK. Because MCF-7 cells already express
endogenous E-cadherin, we repeated this same experiment
Figure 3. Colocalization of E-cadherin and FGFR1 on
lateral membranes and in endosomes. (A) MCF-7 cells
were transiently transfected with FGFR1-GFP (green)
and either grown in serum without (top) or with (bot-
tom) exogenous FGF-1, fixed, and stained for endoge-
nous E-cadherin (red). Insets depict confocal imaging of
E-cadherin and FGFR1-GFP. Note colocalization with
E-cadherin in endosomes. (B) MCF-7 cells were tran-
siently transfected with GFP-Rab5Q79L alone (green, top)
or cotransfected with FGFR1-GFP (green) and myc-
Rab5Q79L (red, bottom). Cells were incubated with FGF-1
for 2 h at 37°C, fixed, and stained using a myc (bottom)
or E-cadherin antibody (top) and imaged for GFP and
immunofluorescence. Insets depict cropped, higher-
magnification examples of colocalization of FGFR1-GFP
with Rab5Q79L. Bar, 50 m.
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in wild-type Chinese hamster ovary cells, which do not
express E-cadherin. Overexpression of E-cadherin in this
context also attenuated MAPK signaling (as measured by
ERK activation) in response to FGF (our unpublished data).
Together, our results indicate that E-cadherin has a direct
and suppressive effect on signaling to the MAPK pathway
by FGF/FGFR, with E-cadherin attenuating both the level
and duration of MAPK activation. This stands as further
evidence that E-cadherin can directly affect both the traffick-
ing and function of FGFR.
Conjoint Regulation of E-Cadherin Endocytosis and
FGFR1 Nuclear Translocation by p120ctn
p120ctn has demonstrated roles in regulating stability and
endocytosis of cadherin at the plasma membrane (Davis et
al., 2003; Xiao et al., 2003); in particular, p120ctn overexpres-
sion was found to block VE-cadherin endocytosis in endo-
thelial cells. Thus, p120ctn (p120-GFP) was transiently over-
expressed in MCF-7 cells, as an independent means of
regulating E-cadherin endocytosis. Cells were then stimu-
lated with FGF-1 for 2 h to induce internalization of both
E-cadherin and FGFR1. Our results show that overexpres-
sion of p120-GFP also effectively inhibits E-cadherin inter-
nalization in epithelial cells, and moreover, FGFR1 nuclear
translocation is simultaneously blocked. Interestingly, these
effects were confluence dependent. In patches of adhesive,
polarized cells, p120-GFP was distinctly localized at points
of cell-cell contact as well as giving cytoplasmic staining. In
these cells, p120ctn overexpression resulted in a complete
inhibition of the internalization of E-cadherin in response to
FGF (Figure 7, a–c, arrow), and a complete absence of nu-
clear FGFR1 staining (Figure 7, g–i). In contrast, internaliza-
tion of E-cadherin in response to FGF was not inhibited in
preconfluent, poorly adherent transfected cells, which dis-
played internal puncta as the predominant localization of
p120-GFP (Figure 7, d–f). Nuclear translocation of FGFR1
followed a similar phenotype in preconfluent cells where
p120-GFP was unable to fully inhibit nuclear translocation of
FGFR1 (Figure 7, j–l), as was expression of EGFP alone
(Figure 4, B and C). Modulation of E-cadherin internaliza-
tion by p120ctn in response to FGF is not therefore due to
levels of p120ctn expression per se, but instead reflects a
functional engagement of p120ctn as part of active adhesive
E-cadherin/catenin complexes at adherens junctions in po-
larized cells. Similarly, nuclear translocation of FGFR1 is
further coupled to the E-cadherin/catenin complex, whereby
stabilization of the complex by p120ctn overexpression also
mitigates nuclear trafficking of FGFR1 in response to FGF.
These results provide further evidence that E-cadherin,
through both stability of adherens junctions and its trafficking,
regulates FGFR1 nuclear translocation and signaling of FGFR1.
DISCUSSION
In this article, we have studied FGFR1 and the E-cadherin/
catenin complex, revealing a novel, conjoint regulation of
the two systems, which is governed by endocytic trafficking.
FGF stimulation revealed two distinct features—nuclear
with values representing 100 cells from triplicate samples. (C)
Quantification of the percentage of cells expressing nuclear FGFR1
labeling after transfection with Rab5S34N-GFP, Dyn2K44A-HA,
ARF6T27N-HA, DN-Eps15-GFP, or EGFP alone and stimulation with
FGF-1 for 4 h. Control cells represent untransfected cells from the
same experiment as mutant transfectants. The error bars represent
mean  SD from triplicate samples.
Figure 4. Nuclear translocation of FGFR1 requires endocytosis of
surface FGFR1. (A) MCF-7 cells transiently transfected with either
GFP-Rab5Q79L (top), Dyn2K44A-HA (second row), ARF6T27N-HA (third
row), or EGFP alone (bottom) were incubated with FGF-1 for 4 h at
37°C, fixed, and stained for FGFR1 (red) and HA (second and third
rows). Bar, 50 m. (B) Quantification of nuclear FGFR1 labeling (per-
centage of cells) after transfection with Rab5Q79L-GFP in either serum-
grown control cells or after stimulation with FGF-1 or FGF-2 for 4 h.
Control cells represent untransfected cells from the same experiment,
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translocation of surface FGFR1 and endocytosis of surface
E-cadherin—that occur concurrently, are governed by the
same molecular mechanisms, and impact on the signaling
and adhesive status of MCF-7 cells. Specifically, the reten-
tion of E-cadherin at cell-cell contacts directly affects the
trafficking and function of FGFR1.
Previous studies have identified developmental and ge-
netic links between the FGF and E-cadherin systems (Ciruna
and Rossant, 2001; Chihara et al., 2003), with a focus primar-
ily on transcriptional regulation of E-cadherin (Thiery, 2002).
However, regulation of E-cadherin endocytosis and recy-
cling presents an equally powerful mechanism for modula-
tion of E-cadherin function (Le et al., 1999; Jarrett et al., 2002).
We set out here to examine the role of endocytosis in regu-
lation of the functional interaction between the FGF and
E-cadherin systems.
The opportunity for conjoint regulation of E-cadherin
with FGFR1 is provided at the outset by six lines of evidence
in the current study: 1) E-cadherin and FGFR1 both inter-
nalize in response to FGF stimulation, confirming that E-
Figure 5. Coendocytosis of E-cadherin is required for nuclear translocation of FGFR1. (A) Immunofluorescence labeling of MCF-7 cells by
using antibodies to E-cadherin (red) and FGFR1 (green), either without (top) or with (bottom) prior incubation with FGF-1 for 24 h at 37°C.
FGF induces changes in the morphology and staining in regions of the monolayer. Outline separates cells with (outside dotted outline) and
without (inside dotted outline) nuclear FGFR1 labeling. (B) MCF-7 cells were transiently transfected with E-cadherin-GFP, incubated with
FGF-1 for 4 h at 37°C, fixed, and stained for immunofluorescence by using an anti-FGFR1 antibody. Arrow depicts particularly strong cell
surface labeling. (C) MCF-7 cells stably overexpressing E-cadherin-GFP were incubated with FGF-1 for 2 h, fixed, and stained for endogenous
FGFR1. (D) Quantification of cells expressing nuclear FGFR1 labeling after transfection with E-cadherin-GFP in either serum-grown control
cells or in cells stimulated with FGF-1 or FGF-2 for 4 h. Control cells represent untransfected cells from the same experiment. (E) Extracts of
wild-type MCF-7 cells (wt-MCF-7) and MCF-7 cells stably overexpressing E-cadherin-GFP (hE-GFP-MCF-7) in serum, or with FGF-1 for 2 h,
and immunoblotted for E-cadherin, FGFR1 and tubulin.
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cadherin lays downstream or at the level of FGFR1 activa-
tion; 2) both proteins internalize into Rab5/EEA1-positive
endosomes and colocalize in intracellular compartments,
revealing that trafficking of both proteins is influenced by
receptor activation; 3) initial internalization and trafficking
are governed by the same molecular mechanisms; 4) FGF
signaling results in deregulation of E-cadherin function, sug-
gesting an inverse regulatory action of FGF on E-cadherin; 5)
overexpression of E-cadherin blocks nuclear translocation of
FGFR1 and attenuates MAPK activation by FGF, revealing a
reciprocal negative regulation of FGFR1 by E-cadherin; and
finally, 6) inhibition of E-cadherin internalization (by
p120ctn) also blocks nuclear translocation of FGFR1.
Since the demonstration that at least some of the nuclear-
localized pool of FGFR1 derives from the cell surface (Ma-
her, 1996), the mechanisms for this translocation have re-
mained elusive. Curiously, FGFR1 contains no detectable
nuclear localization sequence, but it is nonetheless reliant on
importin  for nuclear translocation (Reilly and Maher,
2001). Here, we demonstrate the internalization of FGFR1
into the endocytic pathway is requisite for this nuclear trans-
location. In contrast to previous studies, we also reveal that
both FGF-1 and FGF-2 are able to induce trafficking of
FGFR1 into the nucleus, with equal affinity and over a
similar time course in MCF-7 cells (Maher, 1996; Prudovsky
et al., 1996). Much of the nuclear function of FGFR1 has been
attributed to initiation of proliferation (Reilly and Maher,
2001; Stachowiak et al., 2003), a function that is dependent on
the FGFR tyrosine kinase region (Reilly and Maher, 2001;
Peng et al., 2002). Because interaction of FGFR1 with cAMP-
responsive element complexes is able to regulate the tran-
scription of diverse sets of genes (Stachowiak et al., 2003), it
will be thus of interest to delineate whether this is the sole
role for nuclear-localized FGFR1, or whether FGFR1 may
fulfill other cell type-specific functions.
In our studies, nuclear translocation of FGFR1 occurred
only in those cells with endocytosed surface E-cadherin, or
with extensive disruption of cell-cell contacts. Importantly
then, the molecular machinery components found to regu-
late nuclear translocation of FGFR1 are also known regula-
tors of E-cadherin internalization (Paterson et al., 2003). Fur-
thermore, protein kinase C is a known inducer of both
E-cadherin internalization (Le et al., 1999) and of nuclear
translocation of FGFR1 (Peng et al., 2002). Conjoint internal-
ization of cell surface E-cadherin and FGFR1 in response to
FGF provides a functional mechanism for coregulation of
adhesion and signaling. And although we show that both
proteins localize to early endosomes, this does not exclude
the possibility that they may also cotraffic to other subse-
quent compartments, such as recycling or late endosomes.
Interestingly, in the short times studied, the transforming
function of FGF did not result from a marked loss of E-
cadherin expression, but instead resulted from trafficking of
E-cadherin to early endosomes, potentially into a recycling
pool. This highlights the potential for endocytosis to be an
additional, and perhaps early, mechanism for down-regu-
Figure 6. E-cadherin attenuates FGF signaling to the
MAPK pathway. Wild-type MCF-7 cells (wt-MCF-7) or
MCF-7 cells stably overexpressing high levels of human
E-cadherin-GFP (hE-GFP-MCF-7) were grown to con-
fluence, serum-starved for 18 h, and either unstimulated
(control) or incubated with FGF-1 for 10 min, 2 h, or 18 h
and analyzed by SDS-PAGE and immunoblotting by
using antibodies against total MEK1/2 (t-MEK) and
ERK1/2 (t-ERK) or phosphorylated MEK1/2 (p-MEK)
and ERK1/2 (p-ERK). Densitometric analysis of
MEK1/2 and ERK1/2 activation in response to FGF-1,
compared with control, unstimulated cells also was per-
formed. Phosphorylated pools in wt-MCF-7 cells, uncol-
ored; phosphorylated pools in hE-GFP-MCF-7 cells,
black columns.
Figure 7. p120ctn regulates endocytosis of E-cadherin and nuclear
translocation of FGFR1. Immunofluorescence images of MCF-7 cells
transiently transfected with p120-GFP, incubated with FGF-1 for 2 h
at 37°C, fixed, and stained for endogenous E-cadherin (a and d, red)
and FGFR1 (g and j, green). In polarized cells, a–c and g–i, trans-
fected cells have no nuclear labeling of FGFR1, whereas in precon-
fluent cells, d–f and j–l, FGFR1 is still found in the nucleus of
transfected cells. Bar, 50 m.
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lating E-cadherin function downstream of RTKs, separate or
in addition to transcriptional repression over longer times
(Ciruna and Rossant, 2001; Montero et al., 2001; Lu et al.,
2003).
Microdomain organization at the plasma membrane is of
emerging importance to the individual and perhaps joint
functions of E-cadherin and FGFR1. E-cadherin is present in
both stable adhesive complexes and in a separate pool that is
available for endocytosis and constitutive recycling (Le et al.,
1999; Izumi et al., 2004). The microdomain organization of
FGF receptors at the cell surface, for instance into glyco-
sphingolipid-enriched microdomains, directly regulates
their signaling capabilities to both MAPK and c-Src (Toledo
et al., 2004), in an adhesion-dependent manner. Thus, a
model supported by our observations is that, upon FGF
ligation, FGFR1 and E-cadherin move into a membrane mi-
crodomain from which they can both be endocytosed.
Whether this is due to a more direct, physical interaction
between E-cadherin and FGFR1 is a controversial issue (El-
Hariry et al., 2001; Suyama et al., 2002) and awaits further
investigation in our system. This reorganization precedes
their coendocytosis, which in turn is necessary for nuclear
translocation and signaling by FGFR1. Overexpression of
E-cadherin or the function of p120ctn act to suppress this
phenomenon by stabilizing E-cadherin in adhesive junc-
tional complexes (Fujita et al., 2002; Davis et al., 2003; Xiao et
al., 2003). Indeed, levels of E-cadherin have been shown to
regulate EGFR and c-Met signaling (Qian et al., 2004), and it
will be of interest to see whether p120ctn can similarly reg-
ulate the function of other RTKs.
A number of recent studies have suggested that E-cad-
herin–mediated PI3K/Akt signaling can, in some instances,
account for attenuation of the MAPK pathway (Rommel et
al., 1999; Zimmermann and Moelling, 1999; Laprise et al.,
2004); however, discrepancies exist as to the level at which
E-cadherin attenuates RTK signaling (Qian et al., 2004). We
here provide the first evidence that internalization and co-
trafficking of both complexes is a further mechanism for
coregulation of such processes. Suyama et al. (2002) suggest
modulation of FGFR internalization by N-cadherin as a po-
tential mechanism for regulation of cadherin/RTK function,
and we here show directly that FGFR1 internalization and
signaling to MAPK are modulated by E-cadherin. It will be
of interest to see whether the cross talk demonstrated be-
tween E-cadherin and other receptor molecules (e.g., EGFR,
Qian et al., 2004; V1 integrin, Avizienyte et al., 2002) also
involves modulation of intracellular trafficking.
Overall, this study provides the first example of comodu-
lation of a cadherin and RTK by endocytic trafficking, dem-
onstrating modulation of RTK signaling and function tightly
coupled to cell adhesive status and morphology. Impor-
tantly, we show that E-cadherin attenuates FGF signaling. It
is now well recognized that a critical event during metastatic
transformation of some epithelial cells is the switch from
E-cadherin to N-cadherin expression (Cavallaro and
Christofori, 2004). Indeed, in MCF-7 cells, ectopically ex-
pressed N-cadherin binds to FGFRs to enhance signaling
and metastatic behavior (Suyama et al., 2002). In contrast to
N-cadherin, E-cadherin may conversely act to suppress FGF-
induced transformation through direct regulation of FGFR
signaling and intracellular trafficking.
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